{"transactions":[{"id":2583043,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":135822,"kind":"person","name":"Sullivan John F","position":1,"cik":"0001774273","reported_name":"Sullivan John F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Quality & Engineering"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-09-01T21:04:44.000Z","date":"2021-08-30","kind":"exercise","acquired":false,"shares":3200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested."}],"balance_after":15772,"derivative":{"exercise_price":0.28,"expiration_date":"2023-05-29","underlying":"Common Stock","underlying_shares":3200},"source":{"system":"sec-edgar","filing":"0000899243-21-034767","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924321034767/doc4.xml","form_type":"4"}},{"id":2583042,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":135822,"kind":"person","name":"Sullivan John F","position":1,"cik":"0001774273","reported_name":"Sullivan John F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Quality & Engineering"}}],"security":"Common Stock","published_at":"2021-09-01T21:04:44.000Z","date":"2021-08-30","kind":"exercise","acquired":true,"shares":3200,"price":0.28,"value":896.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 245 shares acquired under the TransMedics Group, Inc. 2019 Employee Stock Purchase Plan."}],"balance_after":14273,"source":{"system":"sec-edgar","filing":"0000899243-21-034767","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924321034767/doc4.xml","form_type":"4"}},{"id":2751784,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":135822,"kind":"person","name":"Sullivan John F","position":1,"cik":"0001774273","reported_name":"Sullivan John F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Quality & Engineering"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-09T23:38:10.000Z","date":"2021-04-07","kind":"exercise","acquired":false,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, June 22, 2017."}],"balance_after":12437,"derivative":{"exercise_price":2.21,"expiration_date":"2027-06-22","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0000899243-21-015506","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924321015506/doc4.xml","form_type":"4"}},{"id":2751783,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":135822,"kind":"person","name":"Sullivan John F","position":1,"cik":"0001774273","reported_name":"Sullivan John F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Quality & Engineering"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-09T23:38:10.000Z","date":"2021-04-07","kind":"exercise","acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 27, 2020."}],"balance_after":12000,"derivative":{"exercise_price":16.14,"expiration_date":"2030-02-27","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0000899243-21-015506","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924321015506/doc4.xml","form_type":"4"}},{"id":2751782,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":135822,"kind":"person","name":"Sullivan John F","position":1,"cik":"0001774273","reported_name":"Sullivan John F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Quality & Engineering"}}],"security":"Common Stock","published_at":"2021-04-09T23:38:10.000Z","date":"2021-04-07","kind":"sale","acquired":false,"shares":3949,"price":37.46,"value":147929.54,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $37.20 to $37.75 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":10828,"source":{"system":"sec-edgar","filing":"0000899243-21-015506","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924321015506/doc4.xml","form_type":"4"}},{"id":2751781,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":135822,"kind":"person","name":"Sullivan John F","position":1,"cik":"0001774273","reported_name":"Sullivan John F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Quality & Engineering"}}],"security":"Common Stock","published_at":"2021-04-09T23:38:10.000Z","date":"2021-04-07","kind":"sale","acquired":false,"shares":8984,"price":36.77,"value":330341.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $36.20 to $37.18 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":14777,"source":{"system":"sec-edgar","filing":"0000899243-21-015506","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924321015506/doc4.xml","form_type":"4"}},{"id":2751780,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":135822,"kind":"person","name":"Sullivan John F","position":1,"cik":"0001774273","reported_name":"Sullivan John F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Quality & Engineering"}}],"security":"Common Stock","published_at":"2021-04-09T23:38:10.000Z","date":"2021-04-07","kind":"sale","acquired":false,"shares":2067,"price":35.86,"value":74122.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $35.20 to $35.16 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":23761,"source":{"system":"sec-edgar","filing":"0000899243-21-015506","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924321015506/doc4.xml","form_type":"4"}},{"id":2751779,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":135822,"kind":"person","name":"Sullivan John F","position":1,"cik":"0001774273","reported_name":"Sullivan John F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Quality & Engineering"}}],"security":"Common Stock","published_at":"2021-04-09T23:38:10.000Z","date":"2021-04-07","kind":"exercise","acquired":true,"shares":12000,"price":2.21,"value":26520.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":25828,"source":{"system":"sec-edgar","filing":"0000899243-21-015506","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924321015506/doc4.xml","form_type":"4"}},{"id":2751778,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":135822,"kind":"person","name":"Sullivan John F","position":1,"cik":"0001774273","reported_name":"Sullivan John F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Quality & Engineering"}}],"security":"Common Stock","published_at":"2021-04-09T23:38:10.000Z","date":"2021-04-07","kind":"exercise","acquired":true,"shares":3000,"price":16.14,"value":48420.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":13828,"source":{"system":"sec-edgar","filing":"0000899243-21-015506","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924321015506/doc4.xml","form_type":"4"}},{"id":2828869,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":135822,"kind":"person","name":"Sullivan John F","position":1,"cik":"0001774273","reported_name":"Sullivan John F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Quality & Engineering"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-26T22:49:36.000Z","date":"2021-02-24","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021."}],"balance_after":25000,"derivative":{"exercise_price":38.46,"expiration_date":"2031-02-24","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000899243-21-008450","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924321008450/doc4.xml","form_type":"4"}},{"id":2865685,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":135822,"kind":"person","name":"Sullivan John F","position":1,"cik":"0001774273","reported_name":"Sullivan John F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Quality & Engineering"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-11T13:57:11.000Z","date":"2021-02-09","kind":"exercise","acquired":true,"shares":8600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":0.28,"expiration_date":"2023-03-27","underlying":"Common Stock","underlying_shares":8600},"source":{"system":"sec-edgar","filing":"0000899243-21-005847","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924321005847/doc4.xml","form_type":"4"}},{"id":2865684,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":135822,"kind":"person","name":"Sullivan John F","position":1,"cik":"0001774273","reported_name":"Sullivan John F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Quality & Engineering"}}],"security":"Common Stock","published_at":"2021-02-11T13:57:11.000Z","date":"2021-02-09","kind":"sale","acquired":false,"shares":200,"price":34.18,"value":6836.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":10828,"source":{"system":"sec-edgar","filing":"0000899243-21-005847","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924321005847/doc4.xml","form_type":"4"}},{"id":2865683,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":135822,"kind":"person","name":"Sullivan John F","position":1,"cik":"0001774273","reported_name":"Sullivan John F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Quality & Engineering"}}],"security":"Common Stock","published_at":"2021-02-11T13:57:11.000Z","date":"2021-02-09","kind":"sale","acquired":false,"shares":8400,"price":32.78,"value":275352.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $32.50 to $33.41 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":11028,"source":{"system":"sec-edgar","filing":"0000899243-21-005847","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924321005847/doc4.xml","form_type":"4"}},{"id":2865682,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":135822,"kind":"person","name":"Sullivan John F","position":1,"cik":"0001774273","reported_name":"Sullivan John F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Quality & Engineering"}}],"security":"Common Stock","published_at":"2021-02-11T13:57:11.000Z","date":"2021-02-09","kind":"exercise","acquired":true,"shares":8600,"price":0.28,"value":2408.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":19428,"source":{"system":"sec-edgar","filing":"0000899243-21-005847","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924321005847/doc4.xml","form_type":"4"}},{"id":2901468,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":135822,"kind":"person","name":"Sullivan John F","position":1,"cik":"0001774273","reported_name":"Sullivan John F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Quality & Engineering"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-21T02:00:51.000Z","date":"2021-01-19","kind":"exercise","acquired":false,"shares":9617,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested."}],"balance_after":1000,"derivative":{"exercise_price":0.39,"expiration_date":"2021-09-27","underlying":"Common Stock","underlying_shares":9617},"source":{"system":"sec-edgar","filing":"0000899243-21-002615","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924321002615/doc4.xml","form_type":"4"}},{"id":2901467,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":135822,"kind":"person","name":"Sullivan John F","position":1,"cik":"0001774273","reported_name":"Sullivan John F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Quality & Engineering"}}],"security":"Common Stock","published_at":"2021-01-21T02:00:51.000Z","date":"2021-01-19","kind":"sale","acquired":false,"shares":9617,"price":22.12,"value":212728.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $21.99 to $22.55 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":10828,"source":{"system":"sec-edgar","filing":"0000899243-21-002615","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924321002615/doc4.xml","form_type":"4"}},{"id":2901466,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":135822,"kind":"person","name":"Sullivan John F","position":1,"cik":"0001774273","reported_name":"Sullivan John F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Quality & Engineering"}}],"security":"Common Stock","published_at":"2021-01-21T02:00:51.000Z","date":"2021-01-19","kind":"exercise","acquired":true,"shares":9617,"price":0.39,"value":3750.63,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":20445,"source":{"system":"sec-edgar","filing":"0000899243-21-002615","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924321002615/doc4.xml","form_type":"4"}},{"id":2934078,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":135822,"kind":"person","name":"Sullivan John F","position":1,"cik":"0001774273","reported_name":"Sullivan John F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Quality & Engineering"}}],"security":"Common Stock","published_at":"2020-12-22T21:19:19.000Z","date":"2020-12-21","kind":"sale","acquired":false,"shares":1000,"price":17.99,"value":17990.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $17.66 to $18.35 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":10828,"source":{"system":"sec-edgar","filing":"0000899243-20-034833","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924320034833/doc4.xml","form_type":"4"}},{"id":2939072,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":135822,"kind":"person","name":"Sullivan John F","position":1,"cik":"0001774273","reported_name":"Sullivan John F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Quality & Engineering"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-17T22:57:14.000Z","date":"2020-12-16","kind":"exercise","acquired":true,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested."}],"balance_after":10617,"derivative":{"exercise_price":0.39,"expiration_date":"2021-09-27","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0000899243-20-034318","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924320034318/doc4.xml","form_type":"4"}},{"id":2939071,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":135822,"kind":"person","name":"Sullivan John F","position":1,"cik":"0001774273","reported_name":"Sullivan John F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Quality & Engineering"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-17T22:57:14.000Z","date":"2020-12-15","kind":"exercise","acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested."}],"balance_after":11617,"derivative":{"exercise_price":0.39,"expiration_date":"2021-09-27","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0000899243-20-034318","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924320034318/doc4.xml","form_type":"4"}},{"id":2939070,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":135822,"kind":"person","name":"Sullivan John F","position":1,"cik":"0001774273","reported_name":"Sullivan John F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Quality & Engineering"}}],"security":"Common Stock","published_at":"2020-12-17T22:57:14.000Z","date":"2020-12-16","kind":"exercise","acquired":true,"shares":1000,"price":0.39,"value":390.0,"ownership":{"direct":true},"balance_after":11828,"source":{"system":"sec-edgar","filing":"0000899243-20-034318","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924320034318/doc4.xml","form_type":"4"}},{"id":2939069,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":135822,"kind":"person","name":"Sullivan John F","position":1,"cik":"0001774273","reported_name":"Sullivan John F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Quality & Engineering"}}],"security":"Common Stock","published_at":"2020-12-17T22:57:14.000Z","date":"2020-12-15","kind":"sale","acquired":false,"shares":3000,"price":16.63,"value":49890.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $16.50 to $16.81 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":10828,"source":{"system":"sec-edgar","filing":"0000899243-20-034318","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924320034318/doc4.xml","form_type":"4"}},{"id":2939068,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":135822,"kind":"person","name":"Sullivan John F","position":1,"cik":"0001774273","reported_name":"Sullivan John F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Quality & Engineering"}}],"security":"Common Stock","published_at":"2020-12-17T22:57:14.000Z","date":"2020-12-15","kind":"exercise","acquired":true,"shares":3000,"price":0.39,"value":1170.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":13828,"source":{"system":"sec-edgar","filing":"0000899243-20-034318","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924320034318/doc4.xml","form_type":"4"}},{"id":3221993,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":135822,"kind":"person","name":"Sullivan John F","position":1,"cik":"0001774273","reported_name":"Sullivan John F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Quality & Engineering"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-06T23:14:08.000Z","date":"2020-02-27","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 27, 2020."}],"balance_after":15000,"derivative":{"exercise_price":16.14,"expiration_date":"2030-02-27","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000899243-20-007517","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924320007517/doc4.xml","form_type":"4"}},{"id":3367702,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":135822,"kind":"person","name":"Sullivan John F","position":1,"cik":"0001774273","reported_name":"Sullivan John F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Quality & Engineering"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-11-18T21:38:34.000Z","date":"2019-11-15","kind":"exercise","acquired":false,"shares":1400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested."}],"balance_after":8600,"derivative":{"exercise_price":0.28,"expiration_date":"2023-03-27","underlying":"Common Stock","underlying_shares":1400},"source":{"system":"sec-edgar","filing":"0000899243-19-027523","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924319027523/doc4.xml","form_type":"4"}},{"id":3367701,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":135822,"kind":"person","name":"Sullivan John F","position":1,"cik":"0001774273","reported_name":"Sullivan John F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Quality & Engineering"}}],"security":"Common Stock","published_at":"2019-11-18T21:38:34.000Z","date":"2019-11-15","kind":"exercise","acquired":true,"shares":1400,"price":0.28,"value":392.0,"ownership":{"direct":true},"balance_after":10828,"source":{"system":"sec-edgar","filing":"0000899243-19-027523","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924319027523/doc4.xml","form_type":"4"}},{"id":3537609,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":135822,"kind":"person","name":"Sullivan John F","position":1,"cik":"0001774273","reported_name":"Sullivan John F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Quality & Engineering"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-06T22:47:45.000Z","date":"2019-05-06","kind":"other","acquired":true,"shares":24437,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price."},{"field":"shares","element":"transactionShares","label":"F2","text":"The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, June 22, 2017."}],"balance_after":24437,"derivative":{"exercise_price":2.21,"expiration_date":"2027-06-22","underlying":"Common Stock","underlying_shares":24437},"source":{"system":"sec-edgar","filing":"0000899243-19-012302","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924319012302/doc4.xml","form_type":"4"}},{"id":3537608,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":135822,"kind":"person","name":"Sullivan John F","position":1,"cik":"0001774273","reported_name":"Sullivan John F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Quality & Engineering"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-06T22:47:45.000Z","date":"2019-05-06","kind":"other","acquired":false,"shares":85530,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price."},{"field":"shares","element":"transactionShares","label":"F2","text":"The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, June 22, 2017."}],"balance_after":0,"derivative":{"exercise_price":0.63,"expiration_date":"2027-06-22","underlying":"Common Stock","underlying_shares":24437},"source":{"system":"sec-edgar","filing":"0000899243-19-012302","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924319012302/doc4.xml","form_type":"4"}},{"id":3537607,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":135822,"kind":"person","name":"Sullivan John F","position":1,"cik":"0001774273","reported_name":"Sullivan John F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Quality & Engineering"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-06T22:47:45.000Z","date":"2019-05-06","kind":"other","acquired":true,"shares":18972,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price."},{"field":"shares","element":"transactionShares","label":"F2","text":"The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested."}],"balance_after":18972,"derivative":{"exercise_price":0.28,"expiration_date":"2023-05-29","underlying":"Common Stock","underlying_shares":18972},"source":{"system":"sec-edgar","filing":"0000899243-19-012302","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924319012302/doc4.xml","form_type":"4"}},{"id":3537606,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":135822,"kind":"person","name":"Sullivan John F","position":1,"cik":"0001774273","reported_name":"Sullivan John F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Quality & Engineering"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-06T22:47:45.000Z","date":"2019-05-06","kind":"other","acquired":false,"shares":66402,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price."},{"field":"shares","element":"transactionShares","label":"F2","text":"The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":0.08,"expiration_date":"2023-05-29","underlying":"Common Stock","underlying_shares":18972},"source":{"system":"sec-edgar","filing":"0000899243-19-012302","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924319012302/doc4.xml","form_type":"4"}},{"id":3537605,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":135822,"kind":"person","name":"Sullivan John F","position":1,"cik":"0001774273","reported_name":"Sullivan John F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Quality & Engineering"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-06T22:47:45.000Z","date":"2019-05-06","kind":"other","acquired":true,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price."},{"field":"shares","element":"transactionShares","label":"F2","text":"The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested."}],"balance_after":10000,"derivative":{"exercise_price":0.28,"expiration_date":"2023-03-27","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-19-012302","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924319012302/doc4.xml","form_type":"4"}},{"id":3537604,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":135822,"kind":"person","name":"Sullivan John F","position":1,"cik":"0001774273","reported_name":"Sullivan John F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Quality & Engineering"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-06T22:47:45.000Z","date":"2019-05-06","kind":"other","acquired":false,"shares":35000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price."},{"field":"shares","element":"transactionShares","label":"F2","text":"The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":0.08,"expiration_date":"2023-03-27","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-19-012302","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924319012302/doc4.xml","form_type":"4"}},{"id":3537603,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":135822,"kind":"person","name":"Sullivan John F","position":1,"cik":"0001774273","reported_name":"Sullivan John F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Quality & Engineering"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-06T22:47:45.000Z","date":"2019-05-06","kind":"other","acquired":true,"shares":14617,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price."},{"field":"shares","element":"transactionShares","label":"F2","text":"The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested."}],"balance_after":14617,"derivative":{"exercise_price":0.39,"expiration_date":"2021-09-27","underlying":"Common Stock","underlying_shares":14617},"source":{"system":"sec-edgar","filing":"0000899243-19-012302","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924319012302/doc4.xml","form_type":"4"}},{"id":3537602,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":135822,"kind":"person","name":"Sullivan John F","position":1,"cik":"0001774273","reported_name":"Sullivan John F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Quality & Engineering"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-06T22:47:45.000Z","date":"2019-05-06","kind":"other","acquired":false,"shares":51162,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price."},{"field":"shares","element":"transactionShares","label":"F2","text":"The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":0.11,"expiration_date":"2021-09-27","underlying":"Common Stock","underlying_shares":14617},"source":{"system":"sec-edgar","filing":"0000899243-19-012302","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924319012302/doc4.xml","form_type":"4"}},{"id":3537601,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":135822,"kind":"person","name":"Sullivan John F","position":1,"cik":"0001774273","reported_name":"Sullivan John F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Quality & Engineering"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-06T22:47:45.000Z","date":"2019-05-06","kind":"other","acquired":true,"shares":285,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price."},{"field":"shares","element":"transactionShares","label":"F2","text":"The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested."}],"balance_after":285,"derivative":{"exercise_price":57.75,"expiration_date":"2020-12-16","underlying":"Common Stock","underlying_shares":285},"source":{"system":"sec-edgar","filing":"0000899243-19-012302","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924319012302/doc4.xml","form_type":"4"}},{"id":3537600,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":135822,"kind":"person","name":"Sullivan John F","position":1,"cik":"0001774273","reported_name":"Sullivan John F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Quality & Engineering"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-06T22:47:45.000Z","date":"2019-05-06","kind":"other","acquired":false,"shares":1000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price."},{"field":"shares","element":"transactionShares","label":"F2","text":"The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":16.5,"expiration_date":"2020-12-16","underlying":"Common Stock","underlying_shares":285},"source":{"system":"sec-edgar","filing":"0000899243-19-012302","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924319012302/doc4.xml","form_type":"4"}},{"id":3537599,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":135822,"kind":"person","name":"Sullivan John F","position":1,"cik":"0001774273","reported_name":"Sullivan John F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Quality & Engineering"}}],"security":"Common Stock","published_at":"2019-05-06T22:47:45.000Z","date":"2019-05-06","kind":"other","acquired":true,"shares":9428,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Common Stock reported herein as being disposed of is common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Agreement and Plan of Merger and Reorganization by and among the Issuer, TransMedics, Inc. and TMDX, Inc., dated April 15, 2019 (the \"Merger Agreement\"), such common stock of TransMedics, Inc. was converted into shares of common stock of the Issuer on a 3.5-for-one basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Common Stock reported herein as being disposed of is common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Agreement and Plan of Merger and Reorganization by and among the Issuer, TransMedics, Inc. and TMDX, Inc., dated April 15, 2019 (the \"Merger Agreement\"), such common stock of TransMedics, Inc. was converted into shares of common stock of the Issuer on a 3.5-for-one basis."}],"balance_after":9428,"source":{"system":"sec-edgar","filing":"0000899243-19-012302","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924319012302/doc4.xml","form_type":"4"}},{"id":3537598,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":135822,"kind":"person","name":"Sullivan John F","position":1,"cik":"0001774273","reported_name":"Sullivan John F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Quality & Engineering"}}],"security":"Common Stock","published_at":"2019-05-06T22:47:45.000Z","date":"2019-05-06","kind":"other","acquired":false,"shares":33000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Common Stock reported herein as being disposed of is common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Agreement and Plan of Merger and Reorganization by and among the Issuer, TransMedics, Inc. and TMDX, Inc., dated April 15, 2019 (the \"Merger Agreement\"), such common stock of TransMedics, Inc. was converted into shares of common stock of the Issuer on a 3.5-for-one basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Common Stock reported herein as being disposed of is common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Agreement and Plan of Merger and Reorganization by and among the Issuer, TransMedics, Inc. and TMDX, Inc., dated April 15, 2019 (the \"Merger Agreement\"), such common stock of TransMedics, Inc. was converted into shares of common stock of the Issuer on a 3.5-for-one basis."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-19-012302","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756262/000089924319012302/doc4.xml","form_type":"4"}}]}